EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Risk of ovarian cancer in women with pelvic inflammatory disease and homologous recombination repair gene mutations under 55: a population-based cohort study

Chenzhao Feng iD, Wanwan Luo iD, Zanhong Wang iD, Xi Cao iD, Chunlin Dong iD, Fuxia Li iD, Rourou Xiao iD, Bin Yang iD, Gang Chen iD, Chaoyang Sun iD, Zhiqiang Han iD, Xingjie Hao iD und 1 weitere

Journal of Gynecologic Oncology · 2025

DOI: 10.3802/jgo.2025.36.e126 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Chenzhao Feng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Pelvic Inflammatory Disease, Recombinational DNA Repair. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NKRDPC, the Key R&D Program of Hubei Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To address the relation among pelvic inflammatory disease (PID), genetic vulnerability and ovarian cancer (OC) risk, we assessed the association between PID and OC risk, alongside the interplay with germline homologous recombination repair (gHR) mutation, utilizing the UK Biobank. METHODS: We conducted a prospective cohort study in the UK Biobank by tracking OC incidences between individuals with and without a PID history. Identification of gHR mutations (BRCA1, BRCA2, RAD51C, RAD51D, BRIP1) carriers were accomplished through paired whole-exome sequencing data. We used Cox's regression models to evaluate the hazard ratios (HRs) for OC risks under PID. RESULTS: In the large prospective cohort study, the adjusted HR for OC in patients with PID was 1.45 (95% confidence interval [CI]=0.90, 2.32) compared with those with non-PID. Intriguingly, age-stratified analysis unveiled a positive association between PID history and OC risk in those aged under 55 years (HR=1.92; 95% CI=1.02, 3.63). Moreover, individuals aged younger than 55 years harboring both a history of PID and gHR mutations exhibited the highest risk of OC (HR=7.40; 95% CI=1.03, 53.10). CONCLUSION: An association between PID and OC risk emerged, notably in the subgroup aged younger than 55 years old. Individuals with both a PID history and gHR mutations exhibited the highest risk of OC. These findings imply PID as a potential precursor for OC, underscoring the importance of early intervention, particularly in the younger population with gHR mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsPelvic Inflammatory DiseaseRecombinational DNA RepairHumansFemaleMiddle AgedAdultProspective StudiesGenetic Predisposition to DiseaseGerm-Line MutationDNA-Binding ProteinsUnited KingdomBRCA2 ProteinBRCA1 ProteinCohort StudiesDNA HelicasesFanconi Anemia Complementation Group ProteinsRisk FactorsAge FactorsIncidenceRNA Helicases

Stichwörter der Autor:innen

Ovarian CancerPelvic Inflammatory DiseaseRecombinational DNA RepairUK Biobank

Substanzen

DNA-Binding ProteinsBRCA2 ProteinRAD51C protein, humanBRCA1 ProteinRAD51D protein, humanBRIP1 protein, humanBRCA2 protein, humanBRCA1 protein, humanDNA HelicasesFanconi Anemia Complementation Group Proteins

Autor:innen und Institutionen

  • Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Obstetrics and Gynecology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Obstetrics and Gynecology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Department of Gynecology, First Affiliated Hospital, Shihezi University, Shihezi, China.

ORCID-Profile: Chenzhao Feng, Wanwan Luo, Zanhong Wang, Xi Cao, Chunlin Dong, Fuxia Li, Rourou Xiao, Bin Yang, Gang Chen, Chaoyang Sun, Zhiqiang Han, Xingjie Hao, Beibei Wang

Förderung

  • NKRDPC
  • the Key R&D Program of Hubei Province
  • Fundamental Research Funds for the Central Universities
  • Beijing Kanghua Foundation for the Development of Traditional Chinese and Western Medicine
  • Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province
  • Nature and Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Feng, C., Luo, W., Wang, Z., Cao, X., Dong, C., Li, F., Xiao, R., Yang, B., Chen, G., Sun, C., Han, Z., Hao, X., & Wang, B. (2025). Risk of ovarian cancer in women with pelvic inflammatory disease and homologous recombination repair gene mutations under 55: a population-based cohort study. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e126

Vancouver

Feng C, Luo W, Wang Z, Cao X, Dong C, Li F, et al. Risk of ovarian cancer in women with pelvic inflammatory disease and homologous recombination repair gene mutations under 55: a population-based cohort study. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e126

BibTeX
@article{Feng2025,
  author = {Feng, Chenzhao and Luo, Wanwan and Wang, Zanhong and Cao, Xi and Dong, Chunlin and Li, Fuxia and Xiao, Rourou and Yang, Bin and Chen, Gang and Sun, Chaoyang and Han, Zhiqiang and Hao, Xingjie and Wang, Beibei},
  title = {Risk of ovarian cancer in women with pelvic inflammatory disease and homologous recombination repair gene mutations under 55: a population-based cohort study},
  journal = {Journal of Gynecologic Oncology},
  year = {2025},
  doi = {10.3802/jgo.2025.36.e126}
}
Kostenlos starten →